Minor Cannabinoids Show Early Promise in Skin-Disease Research
Explores whether minor cannabinoids show early promise for acne, eczema and psoriasis, what lab studies suggest, and why robust human trials are still needed.
Articles
Cannabis and Insomnia: What the Research Actually Shows
Curious if cannabis can help insomnia? Explore what research really shows, its limits, and why CBT-I remains the safer, evidence-based choice.
Tissue Culture Offers Cannabis Growers Cleaner, More Scalable Propagation
Explore cannabis tissue culture: a cleaner, scalable propagation method that preserves genetics and reduces space—while highlighting real-world limits.
Pesticide Residues Were Rare in Regulated Cannabis but Widespread in Illicit Canadian Samples
Pesticide residues were rare in regulated Canadian cannabis but widespread in illicit samples—2023 study highlights why licensed products offer safer choices.
Cannabis May Help Some People Manage Spinal Cord Injury Pain
Cannabis may ease some spinal cord injury pain, but evidence is limited and inconclusive about safety, dosing, and long-term outcomes—read why.
Medical Marijuana Laws Linked to Fewer Foster-Care Entries Citing Parental Drug Abuse
New study examines whether medical marijuana laws alter foster-care reporting and parental drug use classifications—implications for policy and practice.
Cannabis Genome Map Reveals How Repetitive, Virus-Like DNA Shaped THC and CBD Production
Explore a new cannabis genome map built with long-read sequencing to understand how repetitive DNA and gene rearrangements affect THC and CBD production.
Cannabis Use Was Not Linked to Worse Outcomes in Youth at High Risk for Psychosis
A two-year study found cannabis use among youths at high risk for psychosis did not predict worse symptoms or functioning, but it doesn't prove safety.
Cannabis Use Was Not Linked to Higher Heart Attack Odds in a National U.S. Survey
National study on cannabis use and heart health finds no clear link to heart attack risk in midlife, but data limitations and unanswered questions remain.
Minor Cannabinoids Show Early Potential in Skin-Disease Research
Could minor cannabinoids unlock new skin therapies? A 2023 review surveys CBDV, CBC, THCV and more, highlighting potential; early-stage, not proven.